Evotec Takes The Lead On EU-Backed Antibiotic R&D Project
Executive Summary
The 11-member GNA NOW alliance aims to move a treatment for some of the most threatening drug-resistant bacteria through early-phase development by 2024 using a mix of public and private funds.